[1]
2025. TCA as an effective augmentation therapy in case of resistant and recurrent tinea cruris & corporis. Journal of Carcinogenesis. 24, 9s (Oct. 2025), 78–86. DOI:https://doi.org/10.64149/J.Carcinog.24.9s.78-86.